Transplant Surgery »  Meet the Team »  Nephrology »  Flavio Vincenti, M.D.

Flavio Vincenti, M.D.

Clinical Professor of Medicine and Surgery
Departments of Medicine and Surgery
Endowed Chair in Kidney Transplantation

Contact Information

Academic Office
(415) 353-8390
Fax: 415.353.8974
flavio.Vincenti@ucsfmedctr.org

Appointments
(415) 353-1888 Liver
(415) 353-1551 Kidney and Pancreas
Open Popup
  • American University Medical Center of Beirut, BS  - 1971
  • Universite Saint-Joseph Faculty of Medicine, MD - 1975
  • Internal Medicine Residency: American University of Beirut Medical Center
  • Fellow in Nephrology, Emory University School of Medicine, Atlanta, Georgia, July 1, 1973 - June 30, 1975
  • Research Fellow, National Kidney Foundation, July 1, 1974 - June 30, 1975
  • Fellow in Cardiovascular Research Institute (Nephrology) University of California, San Francisco, July 1, 1975 - June 30, 1976
  • American Board of Internal Medicine, Internal Medicine
  • American Board of Internal Medicine, Nephrology - Subspecialty
  • Chronic Kidney Disease
  • End Stage Renal Disease (Kidney Failure)
  • Internal Medicine
  • Kidney Transplantation
  • Living Kidney Donor Transplantation
  • Pancreas Transplantation
  • Transplant Nephrology
  • Transplant Nephrology

Dr. Flavio Vincenti, a kidney and pancreas transplant specialist, is board certified in internal medicine and nephrology. He came to UCSF Medical Center in 1975 for a transplant nephrology fellowship and was appointed a member of the kidney transplant team.

His memberships in professional organizations include the American Society of Nephrology, American Society of Transplantation, International Society of Nephrology and Transplantation Society. He is a co-leader of the kidney section of the Immune Tolerance Network for kidney transplantation. In addition, he is on the editorial board of the American Journal of Kidney Diseases and Graft.

In 1978, Vincenti was one of the authors of an article in the New England Journal of Medicine about the role of blood transfusions in improving kidney transplants. He also wrote a series of articles on the complications of transplants and has been a leading investigator and author on the use of anti interleukin 2 receptor monoclonal antibodies. In addition, he is a proponent of minimizing immunosuppressive drugs after transplants.

 
Most recent publications from a total of 234
  1. Grinyó JM, Del Carmen Rial M, Alberu J, Steinberg SM, Manfro RC, Nainan G, Vincenti F, Jones-Burton C, Kamar N. Safety and Efficacy Outcomes 3 Years After Switching to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: Results From a Phase 2 Randomized Trial. Am J Kidney Dis. 2016 Nov 23. View in PubMed
  2. Wojciechowski D, Vincenti F. Current status of costimulatory blockade in renal transplantation. Curr Opin Nephrol Hypertens. 2016 Nov; 25(6):583-590. View in PubMed
  3. Wojciechowski D, Vincenti F. Costimulatory Blockade and Use of mTOR Inhibitors: Avoiding Injury Part 2. Adv Chronic Kidney Dis. 2016 Sep; 23(5):306-311. View in PubMed
  4. Klintmalm GB, Vincenti F, Kirk A. Steroid-Responsive Acute Rejection Should Not Be the End Point for Immunosuppressive Trials. Am J Transplant. 2016 Nov; 16(11):3077-3078. View in PubMed
  5. Vincenti F. Belatacept and Long-Term Outcomes in Kidney Transplantation. N Engl J Med. 2016 Jun 30; 374(26):2600-1. View in PubMed
  6. Webber AB, Vincenti F. An Update on Calcineurin Inhibitor-Free Regimens: The Need Persists, but the Landscape has Changed. Transplantation. 2016 Apr; 100(4):836-43. View in PubMed
  7. Vincenti F, Rostaing L, Grinyo J, Rice K, Steinberg S, Gaite L, Moal MC, Mondragon-Ramirez GA, Kothari J, Polinsky MS, Meier-Kriesche HU, Munier S, Larsen CP. Belatacept and Long-Term Outcomes in Kidney Transplantation. N Engl J Med. 2016 Jan 28; 374(4):333-43. View in PubMed
  8. Wolf M, Weir MR, Kopyt N, Mannon RB, Von Visger J, Deng H, Yue S, Vincenti F. A Prospective Cohort Study of Mineral Metabolism After Kidney Transplantation. Transplantation. 2016 Jan; 100(1):184-93. View in PubMed
  9. Sigdel TK, Bestard O, Tran TQ, Hsieh SC, Roedder S, Damm I, Vincenti F, Sarwal MM. A Computational Gene Expression Score for Predicting Immune Injury in Renal Allografts. PLoS One. 2015; 10(9):e0138133. View in PubMed
  10. Vincenti F, Silva HT, Busque S, O'Connell PJ, Russ G, Budde K, Yoshida A, Tortorici MA, Lamba M, Lawendy N, Wang W, Chan G. Evaluation of the effect of tofacitinib exposure on outcomes in kidney transplant patients. Am J Transplant. 2015 Jun; 15(6):1644-53. View in PubMed
  11. View All Publications
Publications provided by UCSF Profiles, powered by CTSI at UCSF. View profile of Flavio Vincenti, M.D.
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.

X